苯胺是一种广泛使用的化学品。长期或高剂量暴露于苯胺可导致肝细胞损伤。虽然在以前的研究中已经建立了苯胺的肝致病性,在苯胺诱导的肝损伤过程中涉及致病基因的研究是有限的。我们的研究首次发现并确定了新的circRNAmmu_circ_26984在苯胺诱导的化学肝损伤中的作用和机制。Further,我们讨论了N-乙酰半胱氨酸(NAC)在该通路中的保护作用。在构建苯胺治疗的体外和体内模型后,我们通过circRNA微阵列分析筛选了在对照组和苯胺处理组的AML12细胞中表达有显著差异的circRNA。接下来,使用RNA下拉,液相色谱-质谱(LC-MS),和RNA免疫沉淀,我们分析了mmu_circ_26984与肌球蛋白重链9(Myh9)之间的关系。随后,我们使用细胞计数试剂盒8,Westernblot确定了mmu_circ_26984和Myh9在苯胺诱导的肝损伤中的具体作用机制以及NAC对苯胺诱导的肝损伤过程的保护作用,RNA提取,逆转录定量聚合酶链反应(RT-qPCR),荧光原位杂交,免疫组织化学,和免疫荧光。与对照组相比,苯胺处理小鼠的肝组织和AML12细胞中mmu_circ_26984的表达显着增加。这种mmu_circ_26984的高表达增加了损伤相关炎症因子的表达,如NLRP3,Caspase-1,IL-18和IL-1β的体内和离体,这加剧了肝损伤的程度。mmu_circ_26984与Myh9的相互作用也影响了肝损伤的进程。Mmu_circ_26984过表达和降低处理影响了AML12细胞中Myh9的表达水平,以及与损伤相关的下游炎症因子,例如NLRP3。此外,NAC减轻了mmu_circ_26984/Myh9/NLRP3轴介导的肝损伤过程。总之,mmu_circ_26984是苯胺诱导的肝损伤过程中潜在的分子标记和治疗靶点,可以通过调节mmu_circ_26984/Myh9/NLRP3轴介导苯胺暴露诱导的肝损伤,和NAC可以有效减弱这种肝损伤的作用。
Aniline is a widely used chemical. Chronic or high-dose exposure to
aniline can lead to hepatocellular damage. Although the hepatic pathogenicity of
aniline has been established in previous studies, studies involving pathogenic genes during
aniline-induced liver injury are limited. Our study first discovered and identified the role and mechanism underlying a new circRNA mmu_circ_26984 in aniline-induced chemical liver injury. Further, we discuss the protective effect of N-acetylcysteine (NAC) in this pathway. After constructing in vitro and in vivo models of aniline treatment, we screened the circRNA with significant differences in expression in AML12 cells from control and
aniline-treated groups by circRNA microarray analysis. Next, using RNA pulldown, liquid chromatography-mass spectrometry (LC-MS), and RNA immunoprecipitation, we analyzed the relationship between mmu_circ_26984 and myosin heavy chain 9 (Myh9). Subsequently, we determined the specific mechanism of action of mmu_circ_26984 and Myh9 in aniline-induced liver injury and the protective effect of NAC against aniline-induced liver injury process using Cell Counting Kit-8, Western blot, RNA extraction, a reverse transcription quantitative polymerase chain reaction (RT-qPCR), fluorescence in situ hybridization, immunohistochemistry, and immunofluorescence. The expression of mmu_circ_26984 was significantly increased in liver tissues and AML12 cells of aniline-treated mice compared with the control group. This high expression of mmu_circ_26984 increased the expression of injury-related inflammatory factors, such as NLRP3, Caspase-1, IL-18, and IL-1β in vivo and ex vivo, which exacerbated the level of liver injury. The interaction of mmu_circ_26984 with Myh9 also affected the course of liver injury. Mmu_circ_26984 overexpression and reduced treatment affected the levels of Myh9 expression in AML12 cells, as well as downstream inflammatory factors associated with injury, such as NLRP3. In addition, NAC reduced the process of liver injury mediated by the mmu_circ_26984/Myh9/NLRP3 axis. In conclusion, mmu_circ_26984 is a potential molecular marker and therapeutic target in the process of aniline-induced liver injury that can mediate aniline-exposure-induced liver injury via modulation of the mmu_circ_26984/Myh9/NLRP3 axis, and NAC can effectively attenuate the effect of this liver injury.